Literature DB >> 10826572

High risk human papillomavirus in women with normal cervical cytology prior to the development of abnormal cytology and colposcopy.

E H Hopman1, L Rozendaal, F J Voorhorst, J M Walboomers, P Kenemans, T J Helmerhorst.   

Abstract

OBJECTIVE: To study the significance of the presence of high risk human papillomavirus (HPV) in women with initially normal cervical cytology for the development of abnormal cytology and an abnormal colposcopic impression.
DESIGN: Prospective, observational study PARTICIPANTS AND METHODS: Sixty-eight women with cytomorphologically normal smears and at least one positive HPV test result were evaluated every six months by cytology, colposcopy and HPV testing. The endpoint of the study was abnormal cervical cytology.
RESULTS: The median time of follow up from the first positive HPV test was 34 months. A total of 17 women developed abnormal cytology, of whom 16 (94%) had persistence of a high risk HPV infection. Women with persistent high risk HPV were more likely to develop abnormal cervical cytology than women without high risk HPV (hazard ratio 28.2, 95% CI 3.72-215.2); they also had an increased risk of developing an abnormal colposcopic impression (hazard ratio 4.4, 95% CI 1.69-11.7). Among the 17 women with abnormal cytology, high grade dysplasia was histopathologically demonstrated in eight women.
CONCLUSION: Persistent presence of high risk HPV in normal cervical smears is associated with a significantly increased risk of developing abnormal cytology and to a lesser degree with developing an abnormal colposcopic impression.

Entities:  

Mesh:

Year:  2000        PMID: 10826572     DOI: 10.1111/j.1471-0528.2000.tb13299.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  12 in total

1.  HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study.

Authors:  Murat Gök; Daniëlle A M Heideman; Folkert J van Kemenade; Johannes Berkhof; Lawrence Rozendaal; Johan W M Spruyt; Feja Voorhorst; Jeroen A M Beliën; Milena Babovic; Peter J F Snijders; Chris J L M Meijer
Journal:  BMJ       Date:  2010-03-11

2.  Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test.

Authors:  D C Rijkaart; V M H Coupe; F J van Kemenade; D A M Heideman; A T Hesselink; W Verweij; L Rozendaal; R H Verheijen; P J Snijders; J Berkhof; C J L M Meijer
Journal:  Br J Cancer       Date:  2010-08-31       Impact factor: 7.640

Review 3.  Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis.

Authors:  Anne F Rositch; Jill Koshiol; Michael G Hudgens; Hilda Razzaghi; Danielle M Backes; Jeanne M Pimenta; Eduardo L Franco; Charles Poole; Jennifer S Smith
Journal:  Int J Cancer       Date:  2012-10-11       Impact factor: 7.396

Review 4.  Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis.

Authors:  Jill Koshiol; Lisa Lindsay; Jeanne M Pimenta; Charles Poole; David Jenkins; Jennifer S Smith
Journal:  Am J Epidemiol       Date:  2008-05-15       Impact factor: 4.897

5.  HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications.

Authors:  D C Rijkaart; J Berkhof; F J van Kemenade; V M H Coupe; L Rozendaal; D A M Heideman; R H M Verheijen; S Bulk; W Verweij; P J F Snijders; C J L M Meijer
Journal:  Br J Cancer       Date:  2012-01-17       Impact factor: 7.640

6.  HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears.

Authors:  G D Zielinski; P J Snijders; L Rozendaal; F J Voorhorst; H C van der Linden; A P Runsink; F A de Schipper; C J Meijer
Journal:  Br J Cancer       Date:  2001-08-03       Impact factor: 7.640

7.  Estimation of the prevalence and distribution of HPV genotypes and identification of related risk factors among Turkish women.

Authors:  Mehmet Kulhan; Nur G Kulhan; Yasemin Seven; Umit A Nayki; Cenk Nayki; Nahit Ata; Pasa Ulug
Journal:  Contemp Oncol (Pozn)       Date:  2017-09-29

Review 8.  Worldwide incidence of cervical lesions: a systematic review.

Authors:  J Ting; A F Rositch; S M Taylor; L Rahangdale; H M Soeters; X Sun; J S Smith
Journal:  Epidemiol Infect       Date:  2014-05-30       Impact factor: 4.434

9.  Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination.

Authors:  Jeremy D Goldhaber-Fiebert; Natasha K Stout; Jesse Ortendahl; Karen M Kuntz; Sue J Goldie; Joshua A Salomon
Journal:  Popul Health Metr       Date:  2007-10-29

10.  Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study.

Authors:  M H Uijterwaal; B I Witte; F J Van Kemenade; D Rijkaart; R Ridder; J Berkhof; G A M A Balfoort-van der Meij; M C G Bleeker; P J F Snijders; C J L M Meijer
Journal:  Br J Cancer       Date:  2014-02-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.